Pfizer has updated its clinical trial data access policy with the goal of simplifying and broadening access to information gathered from clinical trials. The updated policy expands the company’s established methods of clinical trial information sharing, including publication of results from all interventional clinical trials in patients, and its efforts to provide clinical trial results and medical data to study participants.   Pfizer’s expanded policy, effective January 1, 2014, inc...